[Case Report] Circulating microaggregates as biomarkers for the Post‐COVID syndrome, 2024, Hermann et al.

That's Figure 1. Top row is before treatment; bottom row is after treatment
The left panel shows DNA. They say the small blue dots are the mitochondria in the thrombocytes (platelets) which are clustered with some white blood cells (larger blue shapes). The middle red panel is

The right panel is just the two other images overlaid on each other.

 

I don't know what to make of this, other than, of course, it's a case study of one case from a clinic, and so suggestions of recovery could very easily not mean a lot. People often do recover from Post-Covid syndrome. The paper doesn't tell us how long the woman had been sick before starting treatment.

Also, the paper serves as an advertisement for the clinic. Maybe our Austrian members know the authors?

I didn't see any indication of the number of these aggregates found before treatment started.
There's also quite a lot of things thrown into the mix e.g.

(myenteric = nerves situated between and supplying the two layers of muscle in the small intestine.)

I am doubtful that the valacyclovir did anything useful - other studies with it have not found any benefit. 'Secondary Hypogonadism' is mentioned as a symptom, which I assume is low oestrogen. There's no report on whether the 'secondary hypogonadism' resolved with the resolution of other symptoms. There's no report of how many months it has been since the 90 Bell score.

I do agree that looking at the blood carefully is a good idea and more of that should be done. While admittedly I would be skeptical of any case study report from a private clinic, there is quite a lot of information missing that would have made the case study more compelling. In addition to the missing information I have already noted, are the clinicians finding their treatment regime is useful in other patients, or is this the first patient they have applied it to? Have they found the microaggregates in other patients?